Results 21 to 30 of about 863,376 (298)

Upper extremity deep venous thrombosis: risk factors, diagnosis, treatment [PDF]

Romanian Journal of Medical Practice, 2016
Upper extremity deep venous thrombosis is a condition with increasing prevalence, with high risk of morbidity and mortality, due to embolic complications.
Camelia C. DIACONU, Mădălina ILIE, Mihaela Adela IANCU   +2 more
doaj   +1 more source

European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology

European Journal of Neurology, 2017
Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010.
J. Ferro, M. Bousser, P. Canhão, J. Coutinho, I. Crassard, F. Dentali, M. D. Minno, A. Maino, I. Martinelli, F. Masuhr, D. Sousa, J. Stam   +11 more
semanticscholar   +2 more sources

Current perspective of venous thrombosis in the upper\ud extremity [PDF]

, 2008
Venous thrombosis of the upper extremity is a rare disease. Therefore, not as much is known about risk factors, treatment and the risk of recurrence as for venous thrombosis of the leg.
Doggen, C.J.M., Flinterman, L.E., Meer, F.J.M. van der, Rosendaal, F.R.   +3 more
core   +3 more sources

Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. [PDF]

, 2021
BACKGROUND: A new syndrome of vaccine-induced immune thrombotic thrombocytopenia (VITT) has emerged as a rare side-effect of vaccination against COVID-19. Cerebral venous thrombosis is the most common manifestation of this syndrome but, to our knowledge,
Arthur-Farraj, Peter, Craven, Brian, CVT After Immunisation Against COVID-19 (CAIAC) collaborators, Ferdinand, Phillip, Hassan-Smith, Ghaniah, Hobson, Esther, Hutchcroft, Christopher, Jones, Matthew, Marigold, Richard, Perry, Richard J, Roffe, Christine, Scully, Marie, Singh, Bhagteshwar, Solomon, Tom, Tamborska, Arina, Warcel, Dana, Webb, Alastair, Werring, David J, White, Daniel, Yeo, Jing Ming, Zhang, Liqun   +20 more
core   +5 more sources

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

Blood, 1996
We have examined the prothrombin gene as a candidate gene for venous thrombosis in selected patients with a documented familial history of venous thrombophilia.
S. Poort, F. Rosendaal, P. Reitsma, RM Bertina   +3 more
semanticscholar   +1 more source

Venous thrombosis in the elderly [PDF]

Journal of Thrombosis and Haemostasis, 2007
While the overall incidence of venous thrombosis is 1-2 per 1000 per year, it is close to 1% per year in the very old. The case-fatality rate of thrombosis is high in the elderly, particularly among those with cancer. The risk of major hemorrhage during anticoagulant treatment is also strongly age-dependent, contributing to the vulnerability of the old
Frits R. Rosendaal, A. van Hylckama Vlieg, Catharina Jacoba Maria Doggen   +2 more
openaire   +3 more sources

Treatment-resistant venous thrombosis and pulmonary embolism in a patient with granulomatosis with polyangiitis: a case report

JA Clinical Reports, 2021
Background We herein present a case of venous thrombosis that developed more than 20 years after diagnosis of granulomatosis with polyangiitis (GPA), although many reports of GPA have described venous thrombosis within 1 year of diagnosis.
Chiharu Wakuda, Yoshitaka Aoki, Sho Sugimura, Takayuki Katsuragawa, Yukako Obata, Soichiro Mimuro, Matsuyuki Doi, Yoshiki Nakajima   +7 more
doaj   +1 more source

Association of prothrombin complexe concentrate with venous thrombosis after cardiac surgery: a case-control study

Frontiers in Cardiovascular Medicine, 2023
BackgroundProthrombin complex concentrate (PCC) enhances coagulation and controls bleeding. We aimed to assess whether perioperative infusion of PCC is associated with venous thrombosis after cardiac surgery.MethodsWe conducted a case-control study of ...
Qiaowei Zheng, Liting Zhang, Tingting Liu, Dong Guan, Weiyi Feng, Saisai Luo   +5 more
doaj   +1 more source

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis [PDF]

, 2002
Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated whether this risk is affected by carriership of hereditary prothrombotic abnormalities.
A. Rumley, Anderson, Bloemenkamp, Daly, E. Daly, F. M. Helmerhorst, F. R. Rosendaal, G. D. O. Lowe, Grady, Grodstein, Hulley, Jick, Kniffin, Lowe, M. Vessey, M. Woodward, Mehta, Nordström, Oger, Rees, Rosendaal, Rosendaal, Silverstein, Stadel, Vandenbroucke, Vessey, Woolf   +26 more
core   +1 more source

Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases [PDF]

, 2018
We collected 1500 patients with myeloproliferative neoplasms (MPN) and arterial or venous thrombosis (935/565), pooling three independent cohorts previously reported. Long-term treatment with antiplatelet drugs or vitamin K-antagonists (VKA) was given to
Barbui T, Betti S, Carobbio A, De Stefano V, Finazzi G, Ghirardi A, Rossi E, Vannucchi AM   +7 more
core   +5 more sources